Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990

Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990–2008

Published:2012-06-26 Issue:3 Volume:134 Page:1257-1268
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Schlichting Jennifer A.,Soliman Amr S.,Schairer Catherine,Schottenfeld David,Merajver Sofia D.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-012-2133-2.pdf

Reference72 articles.

1. Anderson WF, Chen BE, Jatoi I et al (2006) Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer. Breast Cancer Res Treat 100:121–126

2. Anderson WF, Schairer C, Chen BE et al (2005) Epidemiology of inflammatory breast cancer (IBC). Breast Dis 22:9–23

3. Chang S, Alderfer JR, Asmar L et al (2000) Inflammatory breast cancer survival: the role of obesity and menopausal status at diagnosis. Breast Cancer Res Treat 64:157–163

4. Hance KW, Anderson WF, Devesa SS et al (2005) Trends in inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology, and End Results program at the National Cancer Institute. J Natl Cancer Inst 97:966–975

5. Chang S, Parker SL, Pham T et al (1998) Inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology, and End Results program of the National Cancer Institute, 1975–1992. Cancer 82:2366–2372

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy;Clinical Cancer Research;2024-04-17

2. Inflammatory breast cancer: Epidemiologic data and therapeutic results;International Review of Cell and Molecular Biology;2024

3. Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls;The Breast;2023-12

4. Implementation of a Multidisciplinary Inflammatory Breast Cancer Program for Quality Improvement;Clinical Breast Cancer;2023-08

5. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer;Breast Cancer Research and Treatment;2023-07-13